The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

The novel drug reduces the need for burdensome phlebotomy and also addresses fatigue, thereby improving quality of life for ...

Rusfertide could be a new treatment option for patients with polycythemia vera, according to Andrew Kuykendall, MD.

For patients with a rare type of blood cancer, treatment might finally be coming out of the Dark Ages. People with the ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Emerging alternative strategies: starting at lower dose (100 μg) without rapid escalation may improve tolerability Traditional approach (per package insert): dose escalation to maximal tolerated dose ...

the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and polycythemia vera must be excluded. The present case and others in the literature indicate that the ...

From the Medical, Pediatric and X-Ray Treatment Departments of the Massachusetts General Hospital, Boston. Read before the New England Roentgen Ray Society, Boston, February 21, 1936. Hunter ...

Gene therapies challenge ERT dominance in Gaucher’s disease as new data reveals strategic insights, key players, and future ...

Early symptoms may include painless lumps or swelling under the skin, weakness, fatigue, unintentional weight loss, and chills, though many people don’t experience symptoms in the early stages.